GeneScience Pharmaceuticals Co., Ltd.

GeneScience Pharmaceuticals Co., Ltd.


Company description

GeneScience Pharmaceuticals Co Ltd (GenSci) is one of the largest, most profitable and rapidly-growing biopharmaceutical companies in China, with 7 products on the market and over 10 products in the pipeline. GenSci's business is focused on developing, manufacturing and marketing biologics as well as innovative biogenerics. GenSci was awarded the first "Medical Center for Quality Controls of Genetic Engineering Pharmaceuticals" by Chinese Quality Association of Pharmaceuticals (CQAP) in 2007, and the first state genetic engineering "Enterprise's New Drug incubation base" & the state New Drug R&D Major Project of "Eleventh Five-Year Plan" in 2009. GenSci has achieved sustainable successes with rapid growth rates in the past twenty years. One of GenSci's important products, GenLei Jintropin (rhGH, Somatropin for Injection) has been the leading brand of rhGH in China with a dominant market share since launched in 1998.

Quick facts

Sales markets Middle East; Asia; Central/South America
Primary business activity Manufacturer
Affiliated categories: Biopharmaceuticals (general category) |Biosimilars |Generic Hormones & Synthetic Substances More

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 12A33 See our Exhibitor Profile   See full Exhibitor List
20 jun 2017

CPhI & PMEC China 2017

June 20 - 22, 2017 Shanghai, China We were at stand E2D42 See our Exhibitor Profile   See full Exhibitor List
GeneScience Pharmaceuticals Co., Ltd.

Contact information




View all contact information